The FDA has accepted for review the New Drug Application for SYD-101 (atropine sulfate) to slow the progression of myopia in children.

Young adults with myopia who attend school may benefit from lower concentration atropine, which minimizes visual performance disruptions.

In December, the U.S.-based National Academy of Sciences published a report classifying myopia, for the first time, as a ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Myopia treatments include orthokeratology lenses and low-dose atropine, each with potential side effects. A case study revealed esotropia as a possible complication of atropine use in myopia ...

本文研究中，研究人员识别出了一种特殊的神经免疫回路，其中在急性病毒感染期间神经元会通过产生神经肽CGRP来参与T细胞的命运决策。 研究团队 ...

0.05% atropine was associated with a higher incidence of mild side effects, though it was more effective in controlling myopia progression compared to 0.01% atropine or placebo. A new study published ...

Treated with atropine, the patients showed unexpected recovery, and doctors are awaiting details on the toxin to ensure long-term protection. No new cases emerged in the past four days.

He said that patients treated with Atropine have shown positive results. He told ANI that, one of the patients who was first given Atropine and referred to Chandigarh started to recovered.